Article Information
History
- August 22, 2023.
Article Versions
- You are currently viewing Version 1 of this article (August 22, 2023 - 11:42).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- S Toniolo1,2,$,#,*,
- S Zhao3,#,*,
- A Scholcz3,
- B Amein1,
- A Ganse-Dumrath1,
- A J Heslegrave6,7,
- S Thompson2,
- S Manohar1,2,3,
- H Zetterberg4,5,6,7,8,9 and
- M Husain1,2,3,#
- 1Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom
- 2Cognitive Disorders Clinic, JR Hospital, Oxford, United Kingdom
- 3Department of Experimental Psychology, University of Oxford, Oxford, United Kingdom
- 4Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden
- 5Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
- 6UK Dementia Research Institute, UCL, London, United Kingdom
- 7Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, United Kingdom
- 8Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China
- 9Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA
- ↵$Corresponding author; Email: sofia.toniolo{at}ndcn.ox.ac.uk
Posted August 22, 2023.
Digital cognitive test performance and relationship to plasma biomarkers in Alzheimer’s disease
